ObjectiveTo develop the Evidence Grading Scale for Ancient classical prescriptions in Traditional Chinese medicine， assess its reliability and validity， and apply it in practice to provide multi-source evidence for clinical practice guidelines development. MethodsLiterature retrieval was conducted to extract and screen existing evaluation dimensions， then the initial items were summarized using thematic analysis. Experts in the clinical medicine， medical history and literature participated in the Delphi questionnaire survey to evaluate and refine the items. An expert consensus meeting was conducted to finalize the included items， refine the method for items evaluation and evidence grading. The evidence quality rating scale for ancient classical traditional Chinese medicine （TCM） prescriptions was then established and tested for reliability and validity. ResultsThrough literature review， extraction， screening and summarization， a total of 3 dimensions and 12 initial items were formed. Questionnaires were sent to 69 experts to evaluate the initial items， with a questionnaire response rate of 100% and an expert authority coefficient of 0.92. All 12 items were retained for they had importance scores above 4. The Evidence Grading Scale on Ancient classical prescriptions in Traditional Chinese medicine includes 3 dimensions with 12 items. The 3 dimensions includes ancient evidence， inheritance status， and modern application. Each dimension contains 4 items， and each item has a full score of 5 points. The evidence was rated as high-level， moderate-level， and low-level according to the final scores. The content validity index （CVI） of the 12 items was ＞0.9， the average CVI of the scale was 0.98， and the intraclass correlation coefficient （ICC） was 0.90. ConclusionThe Evidence Grading Scale on Ancient classical prescriptions in Traditional Chinese medicine has good reliability and validity， which is practical for use in the development of TCM clinical guidelines and can better support clinical decision-making.

Objective:To explore the dynamic trends of family caregivers' supportive care needs and family resilience in enterostomy patients and to analyze the reciprocal predictive relationship between the two.Methods:This study was longitudinal. Convenience sampling was used to select 370 family primary caregivers of colorectal cancer patients with enterostomy in the Affiliated Cancer Hospital of Xinjiang Medical University and the Xinjiang Bazhou People's Hospital from December 2023 to September 2024 as study subjects. Patients were surveyed using the General Information Questionnaire, Family Hardiness Index, and Supportive Care Needs Survey-Partners and Caregivers at four time points of admission (T1), discharge (T2), one month after surgery (T3), and three months after surgery (T4). Spearman correlation was used to analyze the correlation between supportive care needs of family caregivers of enterostomy patients and family resilience at different time points, and a cross-lagged model was constructed to explore the predictive role of supportive care needs on family resilience.Results:A total of 370 questionnaires were distributed and 336 valid questionnaires were finally recovered, with a valid recovery rate of 90.81% (336/370). Supportive care needs of family caregivers and family resilience of 336 family caregivers of enterostomy patients showed an increasing and then decreasing trend during hospitalization to three months after surgery ( P<0.05). Spearman correlation analysis showed that supportive care needs of family caregivers of enterostomy patients were negatively correlated with family resilience ( P<0.01). Cross-lagged model showed that supportive care needs of family caregivers of enterostomy patients at T1, T2, and T3 negatively predicted family resilience in the next period (β=-0.308, -0.204, and -0.243; all P<0.05), but not vice versa. Conclusions:Family caregiver supportive care needs and family resilience of enterostomy patients showed a dynamic trend of increasing and then decreasing during the hospitalization to three months postoperatively, and family caregiver supportive care needs are able to influence subsequent family resilience. Healthcare professionals should assess the supportive care needs of family caregivers and take targeted measures to meet their supportive care needs in a timely manner, in order to enhance the family resilience, create a good family environment for patients' recovery, and improve the quality of life of patients and their family caregivers.

This article summarized the clinical experience of national TCM master Zhang Zhen in treating gastroesophageal reflux cough by applying the theory of"dredging and regulating qi".Professor Zhang Zhen believes that the pathogenesis of gastroesophageal reflux cough lies in the abnormal ascending and descending of qi movement in the viscera.Specifically,it is manifested as weakness of the spleen and stomach,dysfunction of the pivot mechanism,failure of the liver to dredge and disperse,failure of the lung qi to descend,insufficiency of kidney yang,and failure of the kidney to receive qi.Clinically,the treatment method of dredging and regulating qi is adopted,and the Shutiao Decoction is used as the basic prescription.The disease is treated from three aspects,namely strengthening and regulating the spleen and stomach,soothing the liver and purifying the lung,and tonifying the kidney and helping it receive qi.The regulation of the qi movement of the whole body is organically combined with that of the local areas to jointly smooth the operation of the qi movement throughout the body.It is hoped that this can provide references and ideas for the treatment of gastroesophageal reflux cough in TCM.

Schistosomiasis cirrhosis (SAC), as the core pathological outcome of late-stage schistosomiasis, is an important challenge to global public health. Notably, there is still a significant disease burden, especially in the traditional endemic areas, such as the Yangtze River Basin in China. SAC has unique pathogenic characteristics, including insect-derived molecular-driven disease, chronic inflammation dominated by Th2 immunity, delayed pathogenicity, noticeable symptoms of portal hypertension, and an absence of significant correlation with liver cancer. Therefore, future research should focus on the determinants of individual susceptibility to SAC onset, the core mechanism of liver lesion progression post-pathogen clearance, time nodes, and intervention methods. Additionally, finding the high-risk individuals, analyzing of pathological mechanisms, and optimizing intervention strategies will help in promoting the development of clinical prevention and control and translational research.

This article summarized the clinical experience of national TCM master Zhang Zhen in treating gastroesophageal reflux cough by applying the theory of"dredging and regulating qi".Professor Zhang Zhen believes that the pathogenesis of gastroesophageal reflux cough lies in the abnormal ascending and descending of qi movement in the viscera.Specifically,it is manifested as weakness of the spleen and stomach,dysfunction of the pivot mechanism,failure of the liver to dredge and disperse,failure of the lung qi to descend,insufficiency of kidney yang,and failure of the kidney to receive qi.Clinically,the treatment method of dredging and regulating qi is adopted,and the Shutiao Decoction is used as the basic prescription.The disease is treated from three aspects,namely strengthening and regulating the spleen and stomach,soothing the liver and purifying the lung,and tonifying the kidney and helping it receive qi.The regulation of the qi movement of the whole body is organically combined with that of the local areas to jointly smooth the operation of the qi movement throughout the body.It is hoped that this can provide references and ideas for the treatment of gastroesophageal reflux cough in TCM.

Objective:To explore the dynamic trends of family caregivers' supportive care needs and family resilience in enterostomy patients and to analyze the reciprocal predictive relationship between the two.Methods:This study was longitudinal. Convenience sampling was used to select 370 family primary caregivers of colorectal cancer patients with enterostomy in the Affiliated Cancer Hospital of Xinjiang Medical University and the Xinjiang Bazhou People's Hospital from December 2023 to September 2024 as study subjects. Patients were surveyed using the General Information Questionnaire, Family Hardiness Index, and Supportive Care Needs Survey-Partners and Caregivers at four time points of admission (T1), discharge (T2), one month after surgery (T3), and three months after surgery (T4). Spearman correlation was used to analyze the correlation between supportive care needs of family caregivers of enterostomy patients and family resilience at different time points, and a cross-lagged model was constructed to explore the predictive role of supportive care needs on family resilience.Results:A total of 370 questionnaires were distributed and 336 valid questionnaires were finally recovered, with a valid recovery rate of 90.81% (336/370). Supportive care needs of family caregivers and family resilience of 336 family caregivers of enterostomy patients showed an increasing and then decreasing trend during hospitalization to three months after surgery ( P<0.05). Spearman correlation analysis showed that supportive care needs of family caregivers of enterostomy patients were negatively correlated with family resilience ( P<0.01). Cross-lagged model showed that supportive care needs of family caregivers of enterostomy patients at T1, T2, and T3 negatively predicted family resilience in the next period (β=-0.308, -0.204, and -0.243; all P<0.05), but not vice versa. Conclusions:Family caregiver supportive care needs and family resilience of enterostomy patients showed a dynamic trend of increasing and then decreasing during the hospitalization to three months postoperatively, and family caregiver supportive care needs are able to influence subsequent family resilience. Healthcare professionals should assess the supportive care needs of family caregivers and take targeted measures to meet their supportive care needs in a timely manner, in order to enhance the family resilience, create a good family environment for patients' recovery, and improve the quality of life of patients and their family caregivers.

Schistosomiasis cirrhosis (SAC), as the core pathological outcome of late-stage schistosomiasis, is an important challenge to global public health. Notably, there is still a significant disease burden, especially in the traditional endemic areas, such as the Yangtze River Basin in China. SAC has unique pathogenic characteristics, including insect-derived molecular-driven disease, chronic inflammation dominated by Th2 immunity, delayed pathogenicity, noticeable symptoms of portal hypertension, and an absence of significant correlation with liver cancer. Therefore, future research should focus on the determinants of individual susceptibility to SAC onset, the core mechanism of liver lesion progression post-pathogen clearance, time nodes, and intervention methods. Additionally, finding the high-risk individuals, analyzing of pathological mechanisms, and optimizing intervention strategies will help in promoting the development of clinical prevention and control and translational research.

Ferroptosis,a programmed cell death induced by iron-dependent lipid peroxidation and excessive accumulation of reactive oxygen species,is a key pathological mechanism of neuronal death during the progression of Alzheimer's disease(AD),contributing to the formation of"Ferroptosis Hypothesis"for AD pathogenesis.In recent years,there has been extensive research on therapeutic strategies for AD based on the pathogenic mechanism of ferroptosis,focusing primarily on the dysregulation of brain iron metabolism and redox regulation in microenvironment.However,presence of blood-brain barrier and intricate pathological environment within brain impose limitations on intracranial drug transportation,distribution and therapeutic efficacy,thereby necessitating advancements in drug delivery technology.Based on description of ferroptosis process and its regulatory mechanisms,this review explores the association between iron overload and redox imbalance with neuronal loss and AD development,and additionally,summarizes the advancements in nano drug delivery systems targeting iron overload and redox imbalance for potential anti-AD treatments,so as to offer some novel perspectives for AD treatment and drug development.

Patients with severe trauma require an extremely timely treatment and transfusion plays an irreplaceable role in the emergency treatment of such patients. An increasing number of evidence-based medicinal evidences and clinical practices suggest that patients with severe traumatic bleeding benefit from early transfusion of low-titer group O whole blood or hemostatic resuscitation with red blood cells, plasma and platelet of a balanced ratio. However, the current domestic mode of blood supply cannot fully meet the requirements of timely and effective blood transfusion for emergency treatment of patients with severe trauma in clinical practice. In order to solve the key problems in blood supply and blood transfusion strategies for emergency treatment of severe trauma, Branch of Clinical Transfusion Medicine of Chinese Medical Association, Group for Trauma Emergency Care and Multiple Injuries of Trauma Branch of Chinese Medical Association, Young Scholar Group of Disaster Medicine Branch of Chinese Medical Association organized domestic experts of blood transfusion medicine and trauma treatment to jointly formulate Chinese expert consensus on blood support mode and blood transfusion strategies for emergency treatment of severe trauma patients ( version 2024). Based on the evidence-based medical evidence and Delphi method of expert consultation and voting, 10 recommendations were put forward from two aspects of blood support mode and transfusion strategies, aiming to provide a reference for transfusion resuscitation in the emergency treatment of severe trauma and further improve the success rate of treatment of patients with severe trauma.

Objective:To investigate the efficacy and safety of AcoStream peripheral thrombus aspiration system combined with catheter-directed thrombolysis in the treatment of lower extremity deep vein thrombosis.Methods:The clinical data of 16 lower extremity deep vein thrombosis cases treated with AcoStream peripheral thrombus aspiration system combined with catheter-directed thrombolysis, admitted to the authors′ hospital from May 2022 to November 2022, were retrospectively analyzed. The differences in circumferential diameter between the affected limb and the healthy side, venous patency score, thrombus clearance grade and intraoperative blood loss were observed and compared. The Villalta score was used during the follow up. Paired sample t-test and Wilcoxon rank sum test were used to compare the changes in the observed indicators before and after treatment to evaluate the efficacy. Results:Treatment were successfully performed in all patients. Before treatment, the circumference differences between the affected and unaffected thighs and calves were (3.69±0.97) and (3.34±0.75)cm, respectively, the venous patency score of the affected side was 8(7.25,9) points. After treatment, the circumference differences between the affected and unaffected thighs and calves were (0.81±0.68) and (0.84±0.70)cm, respectively. The venous patency score of the affected side was 1(0,1)points, with statistically significant differences ( P<0.001). Grade Ⅲ thrombus clearance was achieved in 7 patients, grade Ⅱ thrombus clearance was achieved in 9 patients. The average blood loss during thrombus aspiration was (133.1±12.0) ml. Following up for 6 months, the Villalta score was 0(0,1.75) points. Conclusion:Acostream peripheral thrombus aspiration system combined with catheter-directed thrombolysis is safe and effective for the treatment of lower extremity deep venous thrombosis, with satisfactory short-term efficacy and high clinical application value.